Mother of Two Reports Weight Loss With Medication

In 2016, a motorcycle photo prompted Keytsiia to reconsider her health. The mother of two, who works in administration for a North Carolina school district, was then at her highest weight. After her work pants no longer fastened, she met with a doctor. Given a choice between lifestyle changes and bariatric surgery, she chose to eat less and exercise more.

Keytsiia maintained those changes for over three years, but after the first year she had shed only a few pounds. A nutritionist later helped modify her food choices and eating habits, yet the results still fell short of what she wanted. Her doctor proposed a 2.4 mg WEGOVY injection in January 2023. She began using it while continuing her lower-calorie eating plan and physical activity, and says her weight-loss progress then improved.

The medicine is injected beneath the skin of the stomach, thigh, or upper arm. Keytsiia initially experienced nausea and worked with her doctor to manage it. Her activity plan included strength work on three days each week and more everyday movement, such as accumulating additional steps. WEGOVY is prescription semaglutide and is not intended for use alongside another semaglutide product or a different GLP-1 receptor agonist. Listed common effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dizziness, bloating, heartburn, hair loss, and several others. The story was funded by Novo Nordisk; Keytsiia is a paid spokesperson and WEGOVY Patient Ambassador.